Document Detail

Noninvasive prenatal diagnosis: 2010.
MedLine Citation:
PMID:  20638579     Owner:  NLM     Status:  MEDLINE    
Looking for fetal cells and now nucleic acids has been the holy grail of prenatal diagnosis for more than a century. The use of noninvasive diagnostics has potential far beyond aneuploidy; in fact, its use for Rhesus disease is already commonplace in Europe. Accurate segregation of fetal cells from maternal cells or identification of cell-free fetal (cff) DNA or RNA is critical to the development of fetal cells as a screening or diagnostic prenatal technique. The large number of approaches that have been used is testimony to the fact that none of them have been particularly successful. This article discusses the current status and challenges of noninvasive prenatal diagnosis.
Mark I Evans; Michael Kilpatrick
Related Documents :
25227799 - Comparison of inhibitory effects of 17-aag nanoparticles and free 17-aag on hsp90 gene ...
16183089 - Leukocytosis and blood eosinophilia in a polyparasitised population in north-eastern br...
7229929 - Comparison of quantitation methods for l-1210 cell populations and evaluation of select...
11135289 - Quantitative analysis of disseminated tumor cells in the bone marrow by automated fluor...
25344199 - Topographical transcriptome mapping of the mouse medial ganglionic eminence by spatiall...
7409839 - Separation of viable from nonviable cells using a discontinuous density gradient.
4020149 - Fiber optic probe cytometer.
23421999 - Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive...
10508599 - A metalloprotease prepares the way.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinics in laboratory medicine     Volume:  30     ISSN:  1557-9832     ISO Abbreviation:  Clin. Lab. Med.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-07-19     Completed Date:  2010-11-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100174     Medline TA:  Clin Lab Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  655-65     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
Fetal Medicine Foundation of America, New York, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cervix Uteri / cytology
DNA / analysis
Fetus / cytology
Mass Screening / adverse effects,  methods
Maternal-Fetal Exchange
Prenatal Diagnosis / adverse effects,  methods*
RNA / analysis
Risk Assessment
Trophoblasts / chemistry
Reg. No./Substance:
63231-63-0/RNA; 9007-49-2/DNA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Screening and Testing in Multiples.
Next Document:  The Role of Second-Trimester Serum Screening in the Post-First-Trimester Screening Era.